Prostate Cancer Trial, Recruiting (NCT06449664)

Prostate Cancer Trial, Recruiting NCT06449664 Sponsor: The Swedish School of Sport and Health Sciences Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06449664 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to sign a consent form to take part in the study
You have been diagnosed with prostate cancer that is confined to or near the prostate (confirmed by a tissue biopsy or similar test)
You are planned to receive radiation therapy combined with hormone therapy (to reduce testosterone) for at least six months, with the goal of curing the cancer, and your cancer has not spread to other parts of the body

Who may not be able to join:

Your prostate cancer is classified as "very high risk" and your treatment plan includes radiation therapy, hormone therapy, plus additional medications called abiraterone and cortisone
Your prostate cancer treatment plan involves radiation therapy alone, without any hormone therapy
You are currently receiving or have previously received hormone therapy or other treatments that affect hormone levels for your prostate cancer
You have any health conditions or physical limitations that would make exercise or physical fitness testing unsafe for you, based on standard exercise safety guidelines (confirm with trial site)
You are unable or unwilling to follow the study's required procedures and schedule

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06449664

Sponsor: The Swedish School of Sport and Health Sciences

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

More information: https://clinicaltrials.gov/study/NCT06449664

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to sign a consent form to take part in the study
You have been diagnosed with prostate cancer that is confined to or near the prostate (confirmed by a tissue biopsy or similar test)
You are planned to receive radiation therapy combined with hormone therapy (to reduce testosterone) for at least six months, with the goal of curing the cancer, and your cancer has not spread to other parts of the body

Who may not be able to join:

Your prostate cancer is classified as "very high risk" and your treatment plan includes radiation therapy, hormone therapy, plus additional medications called abiraterone and cortisone
Your prostate cancer treatment plan involves radiation therapy alone, without any hormone therapy
You are currently receiving or have previously received hormone therapy or other treatments that affect hormone levels for your prostate cancer
You have any health conditions or physical limitations that would make exercise or physical fitness testing unsafe for you, based on standard exercise safety guidelines (confirm with trial site)
You are unable or unwilling to follow the study's required procedures and schedule

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Swedish School of Sport and Health Sciences

Registry

ClinicalTrials.gov

Start date

1 May 2024

Est. completion

1 December 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Aerobic fitness; Maximal leg strength

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov